MedTrace Logo

Promotion of RSV Immunization Through Multiple Efforts

NCT06640868 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-12-08

No results posted yet for this study

Summary

Central hypothesis: a multimodal approach is needed to enhance RSV vaccine uptake in pregnancy rather than the current standard of care that relies solely on physician recommendations at routine prenatal visits and/or mass messaging to the public. The investigators propose a pilot sequential multiple assignment randomized trial (SMART) to evaluate the effectiveness of a bundle of evidence-based and sequential strategies to test early (28-30 weeks gestation) and late (34-36 weeks gestation efficacy) to increase RSV vaccination during pregnancy.

Conditions

  • Pregnancy
  • Vaccination

Interventions

BEHAVIORAL

MyChart nurse message

Receipt of a MyChart nurse message around 34 weeks encouraging RSV vaccination

BEHAVIORAL

SMFM video

Receipt of SMFM video around 34 weeks encouraging RSV vaccination

BEHAVIORAL

Visual aid

Receipt of a visual aide encouraging RSV vaccination at 28-30 wks

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-04
Primary Completion
2025-02-20
Completion
2025-02-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640868 on ClinicalTrials.gov